相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A Comparative View of Reported Adverse Effects of Statins in Social Media, Regulatory Data, Drug Information Databases and Systematic Reviews (vol 45, pg 613, 2021)
Su Golder et al.
DRUG SAFETY (2021)
Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction A Prespecified Secondary Analysis From the FOURIER Trial
Baris Gencer et al.
JAMA CARDIOLOGY (2020)
Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries
Guy De Backer et al.
ATHEROSCLEROSIS (2019)
Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
Philippe Gabriel Steg et al.
CIRCULATION (2019)
Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)
Konstantinos C. Koskinas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
Connie B. Newman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary
Scott M. Grundy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez et al.
EUROPEAN HEART JOURNAL (2018)
Association of a Combined Measure of Adherence and Treatment Intensity With Cardiovascular Outcomes in Patients With Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe
Kamlesh Khunti et al.
JAMA NETWORK OPEN (2018)
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference et al.
EUROPEAN HEART JOURNAL (2017)
Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014
Robert S. Rosenson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease
Fatima Rodriguez et al.
JAMA CARDIOLOGY (2017)
Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II
Anselm K. Gitt et al.
ATHEROSCLEROSIS (2017)
A systematic review to assess adherence and persistence with statins
Sohan Deshpande et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study
Sune Fallgaard Nielsen et al.
EUROPEAN HEART JOURNAL (2016)
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries
Kornelia Kotseva et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2016)
Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins et al.
LANCET (2016)
The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality
Aurelie Bannay et al.
MEDICAL CARE (2016)
Control Outcomes and Exposures for Improving Internal Validity of Nonrandomized Studies
Stacie B. Dusetzina et al.
HEALTH SERVICES RESEARCH (2015)
Underutilization of High-Intensity Statin Therapy After Hospitalization for Coronary Heart Disease
Robert S. Rosenson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
When Compliance Is an Issue-How to Enhance Statin Adherence and Address Adverse Effects
Kim Birtcher
CURRENT ATHEROSCLEROSIS REPORTS (2015)
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
Gregory G. Schwartz et al.
AMERICAN HEART JOURNAL (2014)
2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Ezra A. Amsterdam et al.
CIRCULATION (2014)
A Polypill Strategy to Improve Global Secondary Cardiovascular Prevention From Concept to Reality
Jose M. Castellano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
How Do We Improve Patient Compliance and Adherence to Long-Term Statin Therapy?
Patricia Maningat et al.
CURRENT ATHEROSCLEROSIS REPORTS (2013)
Standardizing Terminology and Definitions of Medication Adherence and Persistence in Research Employing Electronic Databases
Marsha A. Raebel et al.
MEDICAL CARE (2013)
Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin users
Jerome D. Cohen et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Healthy User and Related Biases in Observational Studies of Preventive Interventions: A Primer for Physicians
William H. Shrank et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2011)
Discontinuation of statin therapy following an acute myocardial infarction: a population-based study
Stella S. Daskalopoulou et al.
EUROPEAN HEART JOURNAL (2008)
Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction
Jeppe N. Rasmussen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
CP Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Clinical inertia
LS Phillips et al.
ANNALS OF INTERNAL MEDICINE (2001)
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes - The MIRACL study: A randomized controlled trial
GG Schwartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)